Table 12.6g

Immunosuppression Use for Maintenance Between Discharge

		Year of Transplant
		1999	2000	2001	2002	2003	2004	2005	2006	2007	2008
Transplants		922	977	1,083	1,054	1,099	1,185	1,407	1,406	1,471	1,478
Tx with Follow-up Immunosuppression Info		665	735	804	829	884	979	1,121	1,144	1,155	1,150
Corticosteroids	Any in Category	99.1%	98.6%	99.5%	97.0%	97.9%	99.3%	99.2%	97.8%	98.9%	99.3%
Corticosteroids	Steroids	99.1%	98.6%	99.5%	97.0%	97.9%	99.3%	99.2%	97.8%	98.9%	99.3%
Cyclosporine	Any in Category	63.8%	54.6%	45.9%	35.2%	30.9%	24.4%	23.0%	17.0%	14.3%	12.6%
	Cyclosporin	0.0%	0.3%	0.5%	0.1%	0.0%	0.1%	0.5%	1.4%	0.8%	1.1%
	Sandimmmune	4.7%	4.2%	5.0%	2.5%	2.7%	1.2%	1.8%	1.6%	1.1%	1.4%
	Neoral	58.6%	48.2%	34.0%	25.9%	20.8%	17.6%	14.9%	9.3%	9.7%	7.9%
	Gengraf	0.3%	1.9%	6.3%	6.5%	7.1%	5.5%	5.5%	4.6%	2.2%	1.9%
	Eon	0.2%	0.0%	0.1%	0.1%	0.2%	0.0%	0.3%	0.1%	0.5%	0.3%
Tacrolimus	Any in Category	46.6%	55.6%	69.2%	75.8%	76.1%	83.7%	85.7%	89.3%	92.3%	91.2%
	Tacrolimus	46.6%	55.6%	69.2%	75.8%	76.1%	83.7%	85.7%	88.6%	91.7%	90.4%
	Everolimus	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.7%	0.6%	0.8%
Antimetabolites	Any in Category	91.4%	94.3%	90.8%	88.8%	87.7%	88.7%	91.8%	92.5%	90.5%	88.4%
	Mycophenolate Mofetil	33.8%	40.8%	42.3%	45.1%	46.5%	49.2%	52.1%	52.0%	52.3%	52.8%
	Mycophenolate Sodium	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	3.4%	3.1%	7.2%	9.1%
	Azathioprine	57.6%	53.3%	48.1%	43.7%	41.2%	39.2%	36.1%	37.4%	30.9%	26.3%
	Leflunomide	0.0%	0.0%	0.2%	0.0%	0.0%	0.0%	0.2%	0.0%	0.1%	0.3%
	Cytoxan	0.0%	0.1%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
mTOR Inhibitors	Any in Category	6.2%	6.3%	11.1%	14.4%	10.3%	8.6%	7.9%	6.7%	6.8%	6.0%
	Sirolimus	5.9%	6.3%	11.1%	14.4%	10.3%	8.6%	7.9%	6.7%	6.8%	6.0%
	Everolimus	0.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%